Episurf Medical AB (publ) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled Determination and visualization of damage to an anatomical joint, relates to 3D-based assessment of joint lesions, and complements Episurf Medical's earlier US patents within this field.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.359 SEK | -2.45% | -49.44% | -63.74% |
Apr. 24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
Apr. 24 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-63.74% | 8.76M | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |
- Stock Market
- Equities
- EPIS B Stock
- News Episurf Medical AB
- Episurf Medical AB Receives Notice of Allowance from the United States Patent and Trademark Office